Found: 412
Select item for more details and to access through your institution.
Impact of amyloid and cardiometabolic risk factors on prognostic capacity of plasma neurofilament light chain for neurodegeneration.
- Published in:
- Alzheimer's Research & Therapy, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13195-024-01564-y
- By:
- Publication type:
- Article
A Lead Study on Oxidative Stress-Mediated Dehydroepiandrosterone Formation in Serum: The Biochemical Basis for a Diagnosis of Alzheimer's Disease.
- Published in:
- Journal of Alzheimer's Disease, 2011, v. 24, n. S2, p. 5
- By:
- Publication type:
- Article
A Lead Study on Oxidative Stress-Mediated Dehydroepiandrosterone Formation in Serum: The Biochemical Basis for a Diagnosis of Alzheimer's Disease.
- Published in:
- Journal of Alzheimer's Disease, 2011, v. 23, n. S1, p. 5, doi. 10.3233/JAD-2011-101941
- By:
- Publication type:
- Article
A lead study on oxidative stress-mediated dehydroepiandrosterone formation in serum: the biochemical basis for a diagnosis of Alzheimer's disease.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-00984-y
- By:
- Publication type:
- Article
Aducanumab produced a clinically meaningful benefit in association with amyloid lowering.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00838-z
- By:
- Publication type:
- Article
High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.
- Published in:
- 2008
- By:
- Publication type:
- journal article
High-Dose B Vitamin Supplementation and Cognitive Decline in Alzheimer Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 2008, v. 300, n. 15, p. 1774, doi. 10.1001/jama.300.15.1774
- By:
- Publication type:
- Article
Effects of Rofecoxib or Naproxen vs Placebo on Alzheimer Disease Progression: A Randomized Controlled Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2003, v. 289, n. 21, p. 2819, doi. 10.1001/jama.289.21.2819
- By:
- Publication type:
- Article
Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer's disease.
- Published in:
- BMC Medical Genomics, 2017, v. 10, p. 45, doi. 10.1186/s12920-017-0267-0
- By:
- Publication type:
- Article
Integration of bioinformatics and imaging informatics for identifying rare PSEN1 variants in Alzheimer's disease.
- Published in:
- BMC Medical Genomics, 2016, v. 9, p. 11, doi. 10.1186/s12920-016-0190-9
- By:
- Publication type:
- Article
Natural cubic splines for the analysis of Alzheimer's clinical trials.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 3, p. 508, doi. 10.1002/pst.2285
- By:
- Publication type:
- Article
BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild-type mice.
- Published in:
- Journal of Neurochemistry, 2006, v. 99, n. 6, p. 1555, doi. 10.1111/j.1471-4159.2006.04178.x
- By:
- Publication type:
- Article
Therapeutics for cognitive aging.
- Published in:
- Annals of the New York Academy of Sciences, 2010, v. 1191, p. E1, doi. 10.1111/j.1749-6632.2010.05532.x
- By:
- Publication type:
- Article
Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer's amyloid, tau and FDG PET status.
- Published in:
- Translational Psychiatry, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41398-021-01709-9
- By:
- Publication type:
- Article
Staging tau pathology with tau PET in Alzheimer's disease: a longitudinal study.
- Published in:
- Translational Psychiatry, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41398-021-01602-5
- By:
- Publication type:
- Article
Inflammation and Alzheimer's Disease: Mechanisms and Therapeutic Strategies.
- Published in:
- Gerontology, 1997, v. 43, n. 1/2, p. 143, doi. 10.1159/000213842
- By:
- Publication type:
- Article
The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI).
- Published in:
- Frontiers in Aging Neuroscience, 2013, p. 1, doi. 10.3389/fnagi.2013.00011
- By:
- Publication type:
- Article
The Role of Apolipoprotein E (APOE) Genotype in Early Mild Cognitive Impairment (E-MCI).
- Published in:
- Frontiers in Aging Neuroscience, 2013, p. 1, doi. 10.3389/fnagi.2013.00011
- By:
- Publication type:
- Article
On the path to 2025: understanding the Alzheimer's disease continuum.
- Published in:
- Alzheimer's Research & Therapy, 2017, v. 9, p. 1, doi. 10.1186/s13195-017-0283-5
- By:
- Publication type:
- Article
Drug development in Alzheimer's disease: the path to 2025.
- Published in:
- Alzheimer's Research & Therapy, 2016, v. 8, p. 1, doi. 10.1186/s13195-016-0207-9
- By:
- Publication type:
- Article
The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2016, v. 8, p. 1, doi. 10.1186/s13195-016-0194-x
- By:
- Publication type:
- Article
Alzheimer's disease progression by geographical region in a clinical trial setting.
- Published in:
- Alzheimer's Research & Therapy, 2015, v. 7, n. 1, p. 1, doi. 10.1186/s13195-015-0127-0
- By:
- Publication type:
- Article
Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer's disease clinical trials.
- Published in:
- Alzheimer's Research & Therapy, 2015, v. 7, n. 1, p. 1, doi. 10.1186/s13195-015-0122-5
- By:
- Publication type:
- Article
Peripheral and central effects of γ-secretase inhibition by semagacestat in Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2015, v. 7, n. 1, p. 1, doi. 10.1186/s13195-015-0121-6
- By:
- Publication type:
- Article
Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2011, v. 3, n. 1, p. 1, doi. 10.1186/alzrt59
- By:
- Publication type:
- Article
Serum Brain-Derived Neurotrophic Factor and the Risk for Dementia.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 311, n. 16, p. 1684, doi. 10.1001/jama.2014.3120
- By:
- Publication type:
- Article
Docosahexaenoic Acid Supplementation and Alzheimer Disease.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease: A Randomized Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2010, v. 304, n. 17, p. 1903, doi. 10.1001/jama.2010.1510
- By:
- Publication type:
- Article
High-Dose B Vitamin Supplements and Alzheimer Disease.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease.
- Published in:
- Journal of Neuroscience Research, 1999, v. 57, n. 3, p. 295, doi. 10.1002/(SICI)1097-4547(19990801)57:3<295::AID-JNR1>3.0.CO;2-0
- By:
- Publication type:
- Article
Anti-inflammatory agents in Alzheimer’s disease.
- Published in:
- Current Neurology & Neuroscience Reports, 2002, v. 2, n. 5, p. 405, doi. 10.1007/s11910-002-0066-6
- By:
- Publication type:
- Article
Tau positron emission tomography in preclinical Alzheimer's disease.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 2, p. 700, doi. 10.1093/brain/awac299
- By:
- Publication type:
- Article
Autosomal dominant and sporadic late onset Alzheimer's disease share a common in vivo pathophysiology.
- Published in:
- 2022
- By:
- Publication type:
- journal article
BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Eligibility Rates among Racially and Ethnically Diverse US Participants in Phase 2 and Phase 3 Placebo‐Controlled, Double‐Blind, Randomized Trials of Lecanemab and Elenbecestat in Early Alzheimer Disease.
- Published in:
- Annals of Neurology, 2024, v. 95, n. 2, p. 288, doi. 10.1002/ana.26819
- By:
- Publication type:
- Article
Tau‐Atrophy Variability Reveals Phenotypic Heterogeneity in Alzheimer's Disease.
- Published in:
- Annals of Neurology, 2021, v. 90, n. 5, p. 751, doi. 10.1002/ana.26233
- By:
- Publication type:
- Article
Protective variant for hippocampal atrophy identified by whole exome sequencing.
- Published in:
- Annals of Neurology, 2015, v. 77, n. 3, p. 547, doi. 10.1002/ana.24349
- By:
- Publication type:
- Article
Mild cognitive impairment due to Alzheimer disease in the community.
- Published in:
- Annals of Neurology, 2013, v. 74, n. 2, p. 199, doi. 10.1002/ana.23931
- By:
- Publication type:
- Article
Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI.
- Published in:
- Acta Neuropathologica, 2011, v. 122, n. 4, p. 401, doi. 10.1007/s00401-011-0861-8
- By:
- Publication type:
- Article
Induction of the complement component C1qB in brain of transgenic mice with neuronal overexpression of human cyclooxygenase-2.
- Published in:
- Acta Neuropathologica, 2002, v. 103, n. 2, p. 157, doi. 10.1007/s004010100447
- By:
- Publication type:
- Article
Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease.
- Published in:
- Annals of Clinical & Translational Neurology, 2015, v. 2, n. 5, p. 534, doi. 10.1002/acn3.192
- By:
- Publication type:
- Article
Stosowanie leku adukanumab przynosi klinicznie istotną korzyść związaną z obniżeniem poziomu amyloidu.
- Published in:
- Current Neurology / Aktualno?ci Neurologiczne, 2021, v. 21, n. 2, p. 111, doi. 10.15557/AN.2021.0014
- By:
- Publication type:
- Article
Elevated Brain Amyloid in Cognitively Normal Individuals-Reply.
- Published in:
- 2017
- By:
- Publication type:
- letter
Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Genome-wide pathway analysis of memory impairment in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort implicates gene candidates, canonical pathways, and networks.
- Published in:
- Brain Imaging & Behavior, 2012, v. 6, n. 4, p. 634, doi. 10.1007/s11682-012-9196-x
- By:
- Publication type:
- Article
AMYLOID-BASED THERAPEUTICS: FINDINGS TRANSLATED INTO NOVEL TREATMENTS.
- Published in:
- Primary Psychiatry, 2008, v. 15, n. Suppl. 6, p. 36
- By:
- Publication type:
- Article
Estimating the Evolution of Disease in the Parkinson's Progression Markers Initiative.
- Published in:
- Neurodegenerative Diseases, 2018, v. 18, n. 4, p. 173, doi. 10.1159/000488780
- By:
- Publication type:
- Article
Plasma Urate and Progression of Mild Cognitive Impairment.
- Published in:
- Neurodegenerative Diseases, 2008, v. 6, n. 1/2, p. 23, doi. 10.1159/000170883
- By:
- Publication type:
- Article